Archive · 12 Aug 2025
Abbott India's Shares Rise Following Strong Q1 Performance
Abbott India, a company that sells medicines, did really well in the first three months of the year!
Their money earned and sales went up by about 12%.
This is good news for the company.
Also, they are going to start selling some new medicines for people with diabetes.
These new medicines include ones that help with blood sugar levels.
Abbott India's shares saw a rise following a strong Q1 performance.
The company's profit and revenue grew by 11.6% in the June quarter compared to the previous year.
Abbott India is set to market MSD Pharmaceuticals’ oral anti-diabetes medications in India.
These medications include sitagliptin and its combination therapies.
- Who
- Abbott India and MSD Pharmaceuticals.
- What
- Abbott India's profit and revenue increased by 11.6% in the June quarter.
- When
- In the June quarter.
- Where
- In India.
- Why
- Not explicitly stated in the article.
- Company
- Abbott India
- Financial Performance
- 11.6% growth in profit and revenue
- Quarter
- June
- New Products
- Oral anti-diabetes medications